Description
Vidalista (Tadalafil) 2.5 mg
Vidalista 2.5 mg is a tadalafil-containing medicine. Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction. The 2.5 mg strength is a recognised once-daily tadalafil dose in prescribing information for erectile dysfunction.
Active Ingredient and Medicine Class
The verified active ingredient is tadalafil. It belongs to the PDE5 inhibitor class. Medicines in this class improve erectile function by enhancing the natural nitric oxide–cGMP pathway in penile tissue.
Established Medical Uses
Regulatory prescribing information supports tadalafil for erectile dysfunction. Some tadalafil products are also approved for benign prostatic hyperplasia and for men with both benign prostatic hyperplasia and erectile dysfunction, depending on the product and jurisdiction. The product name alone does not confirm any indication beyond the verified tadalafil ingredient.
How It Works
Tadalafil inhibits PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP). By slowing cGMP breakdown, it helps relax smooth muscle and increase blood flow in the penis during sexual stimulation. Clinical reviews describe tadalafil as a long-acting PDE5 inhibitor, with effects that can persist for many hours.
Important Safety Information
Tadalafil is contraindicated with nitrates because the combination can cause a dangerous fall in blood pressure. Prescribing information also warns against use with guanylate cyclase stimulators such as riociguat. Caution is needed in men for whom sexual activity is inadvisable because of cardiovascular disease. Important interaction concerns include alpha-blockers, some antihypertensives, and strong CYP3A4 inhibitors, which can increase tadalafil exposure.
Other important precautions include prior vision loss from non-arteritic anterior ischemic optic neuropathy, hearing loss, significant liver or kidney impairment, and conditions that may increase the risk of prolonged or painful erection.
Possible Side Effects
Commonly reported adverse effects include headache, dyspepsia, back pain, myalgia, nasal congestion, flushing, and dizziness. More serious but less common reactions include severe hypotension, priapism, sudden vision loss, and sudden hearing changes.
Scientific Evidence
PubMed-indexed reviews and clinical analyses report that tadalafil improves erectile function across a range of severities and underlying conditions. Evidence also supports both once-daily and on-demand use in erectile dysfunction, with once-daily therapy studied as a continuous treatment approach.
Medical Information Notice
This summary is an educational overview based on sources available at the time of review. It does not replace the official patient leaflet, product label, or assessment by a qualified healthcare professional.
Medical Sources
- FDA — CIALIS (tadalafil) tablets, for oral use — Prescribing Information
- DailyMed — Tadalafil tablet — Full Prescribing Information
- Meuleman EJ et al. “Review of tadalafil in the treatment of erectile dysfunction.” Expert Opinion on Pharmacotherapy. 2003. PubMed
